Our highly-trained staff is very skilled and experienced in Drug Discovery and Development, including safety, efficacy and toxicology studies for IND, NDA and BLA submission. Our scientists have many years of experience in drug development and pharmaceutical companies, are well published and regularly participate in professional conferences and meetings.


  • Jaseem Anwer, Scientific Director

  • Richard W. Shubart, Quality Assurance

  • Matt Lindeblad, Director, Toxicology 

  • Ryan Witt, Growth Advisor

  • Beatriz Gomez, Research Specialist

  • James H. Fischer, Director, Pharmacokinetics